Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
kanglixin capsules
- Development stage
- Unknown
- Lead developer
- Yunnan Mingyang Pharmaceutical
- Administration
- Oral
01
Overview
**Kanglixin capsules** are an oral, eight-component traditional Chinese medicine product manufactured by Yunnan Mingyang Pharmaceutical and approved in China for digestive-tract, breast, and lung malignant tumors associated with the traditional Chinese medicine pattern of qi and blood stasis. The formula contains asafoetida, Aspongopus chinensis, clove, costus root, Cordyceps sinensis, chebulic myrobalan, rhubarb, and turmeric. Its labeled traditional therapeutic principles are strengthening the body's resistance, eliminating pathogenic factors, softening hardness, and dissipating masses. A published randomized study evaluated kanglixin capsules with paclitaxel plus cisplatin chemotherapy in advanced non-small cell lung cancer, while a 2025 network-pharmacology study proposed multi-target activity; however, a clinically established molecular target and mechanism have not been defined.
- Brand names
- Mingyang名扬
- Other names
- Kanglixin JiaonangKLXkanglixin康力欣胶囊
Beyond the preview
Go deeper on kanglixin capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on kanglixin capsules.